Health Notice of exclusive license agreement for artificially modified nucleic acid technology with Takeda Pharmaceutical Company Limited 3 years ago
Health CancerX announces 18 “Cancer Agenda,” which we aim to collectively impact for the society at World Cancer Week 2022. 3 years ago
Health • Technology • XR/VR/AR New Business Partnership Between Otsuka Pharmaceutical and Digital Health VR Technology Developer Jolly Good 3 years ago
Health • Technology A Japanese mental-healthcare app, “Awarefy,” is now available in English 3 years ago
Health • Technology • XR/VR/AR Jolly Good develops a medical VR filming system exclusively for ambulances with physicians 3 years ago
Health • Technology • XR/VR/AR Launching the world’s first all-in-one medical and welfare VR platform JOLLYGOOD+ 3 years ago
Health • Technology • XR/VR/AR Jolly Good launches R&D of VR therapy for chronic pain with Aichi Medical University’s Pain Center. 3 years ago
Health • Technology • XR/VR/AR VR Digital Therapeutics for depression developed in consultation with specialists from Boston, MA, U.S.A., introducing innovative clinical tool at CES2022 3 years ago
Health • Technology JVCKENWOOD to Sell 3D Cell Culture Multi-Well Plate for Drug Discovery through Marketing Alliance with HCS Pharma 3 years ago